Mariana is an investor at Venrock, where she focuses on biotech and pharmaceutical investments. She is the founding investor and director of Interdict Bio and observer at Mythic Tx, Ocelot Bio, MBrace Tx, and Tisento Tx. Prior to Venrock, Mariana was an executive at Celgene Corporation, where she led global development of over a dozen drugs across a diverse set of disease areas (hematology, oncology, inflammation/immunology, neurodegenerative diseases) and modalities (small molecules, biologics, cell therapies). Mariana received her Ph.D. in Biochemistry from Harvard University, MBA from Harvard Business School, and Sc.B. in Biochemistry from Brown University.